<SEC-DOCUMENT>0001367644-23-000135.txt : 20230721
<SEC-HEADER>0001367644-23-000135.hdr.sgml : 20230721
<ACCEPTANCE-DATETIME>20230721082540
ACCESSION NUMBER:		0001367644-23-000135
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230720
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230721
DATE AS OF CHANGE:		20230721

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Emergent BioSolutions Inc.
		CENTRAL INDEX KEY:			0001367644
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				141902018
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33137
		FILM NUMBER:		231101143

	BUSINESS ADDRESS:	
		STREET 1:		400 PROFESSIONAL DR, SUITE 400
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20879
		BUSINESS PHONE:		240-631-3200

	MAIL ADDRESS:	
		STREET 1:		400 PROFESSIONAL DR, SUITE 400
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20879
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ebs-20230720.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:99f6285a-8d8a-49b3-a435-d396b398df7f,g:104a0b2d-2799-4bb5-8bbd-49507b0f7ba4,d:1d0dd832371a4b74a3c3b7971d5ae9b7--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ebs-20230720</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-23">0001367644</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-24">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ebs-20230720.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-20</xbrli:startDate><xbrli:endDate>2023-07-20</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i1d0dd832371a4b74a3c3b7971d5ae9b7_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">July 20, 2023</ix:nonNumeric></ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-4">EMERGENT BIOSOLUTIONS INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.655%"><tr><td style="width:1.0%"></td><td style="width:30.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-5">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-33137</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-7">14-1902018</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-8">400 Professional Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-9">Suite 400</ix:nonNumeric>,</span></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Gaithersburg</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-11">Maryland</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">20879</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">240</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">631-3200</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General Instruction A.2. below):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160; Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-18">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:10pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.109%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-19">Common Stock, Par Value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-20">EBS</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-21">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in&#160;Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-22">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.01 Regulation FD Disclosure.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 20, 2023, Emergent BioSolutions Inc. (the &#8220;Company&#8221;) issued a press release announcing that the U.S. Food and Drug Administration approved CYFENDUS&#8482; (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, for post-exposure prophylaxis of disease following suspected or confirmed exposure to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bacillus anthracis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs. A copy of the Company&#8217;s press release is attached hereto as Exhibit 99.1. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in this Item 7.01 shall not be deemed &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or incorporated by reference in any filing, under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.&#8239; Financial Statements and Exhibits</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (d)         </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.090%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a072023-av7909cyfendusappr.htm">Press release issued by Emergent BioSolutions Inc. on July</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a072023-av7909cyfendusappr.htm"> 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a072023-av7909cyfendusappr.htm">, 2023.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.655%"><tr><td style="width:1.0%"></td><td style="width:50.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EMERGENT BIOSOLUTIONS INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: July 21, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ RICHARD S. LINDAHL</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:  Richard S. Lindahl<br/>Title:  Executive Vice President, Chief Financial<br/>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Officer and Treasurer</span></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a072023-av7909cyfendusappr.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i4e89c121535747e7bbef4150eb450a4c_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="image.jpg" src="image.jpg" style="height:35px;margin-bottom:5pt;vertical-align:text-bottom;width:306px"></div></div><div style="border-color:#ffffff;border-style:solid;border-width:1.00pt;padding:72.00pt 0.00pt 43.20pt 0.00pt"><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Investor Contact&#58;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Robert G. Burrows</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Vice President, Investor Relations</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">240-631-3280</font></div><div style="text-align:right"><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">burrowsr&#64;ebsi.com</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Media Contact&#58;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Matt Hartwig </font></div><div style="text-align:right"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Senior Director, Media Relations </font></div><div style="text-align:right"><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">mediarelations&#64;ebsi.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Emergent BioSolutions Receives U.S. FDA Approval of CYFENDUS&#8482; (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8211;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.24pt">Emergent has been delivering CYFENDUS&#8482; vaccine to the U.S. Department of Health and Human Services since 2019, under pre-Emergency Use Authorization status, and will continue to work with the U.S. government to transition to post-approval procurement</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">GAITHERSBURG, Md.</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8212;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:700;line-height:112%">July 20, 2023</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8212;Emergent BioSolutions Inc. (NYSE&#58;EBS) announced today that the U.S. Food and Drug Administration (FDA) has approved CYFENDUS&#8482; (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, for post-exposure prophylaxis of disease following suspected or confirmed exposure to </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Bacillus anthracis</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs. The efficacy of CYFENDUS&#8482; vaccine for post-exposure prophylaxis is based solely on studies in animal models of inhalational anthrax.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8220;The approval of CYFENDUS&#8482; vaccine is symbolic of Emergent's longstanding partnership with the U.S. government and our shared commitment to helping protect public health,&#8221; said Dr. Kelly Warfield, Emergent&#8217;s senior vice president, science and development. &#8220;The 20-year journey from early development to approval is a major milestone that attests to Emergent's scientific and technical prowess and partnering capabilities. We are grateful for the yearslong collaboration with the Biomedical Advanced Research and Development Authority (BARDA) and early support from the Defense Advanced Research Projects Agency (DARPA) and the National Institute of Allergy and Infectious Diseases (NIAID). Congratulations to the Emergent team and all our partners for advancing this product to approval.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8220;CYFENDUS&#8482; vaccine is a component of the U.S. government&#8217;s preparedness efforts against anthrax, which remains a high-priority national security threat due to its ability to be easily disseminated, lethality, and potential for major public health impact,&#8221; said Paul Williams, Emergent&#8217;s senior vice president, products business. &#8220;The approval of the CYFENDUS&#8482; vaccine demonstrates what effective public-private partnerships can achieve for national security. Emergent will continue to work closely with the U.S. government to transition this product to post-approval procurement while ensuring an uninterrupted supply of this important vaccine.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">CYFENDUS&#8482; vaccine is comprised of Anthrax Vaccine Adsorbed (AVA) and an additional adjuvant. It has been demonstrated that by using an additional adjuvant, two doses administered over 14 days elicit protective levels of immune response, which can be especially important in response to a large-scale public health emergency involving anthrax. In December 2018, CYFENDUS&#8482; vaccine was the subject of a pre-emergency use authorization package submitted to the FDA. The following year, the U.S. government began procuring this product for national preparedness efforts.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">In addition to the CYFENDUS&#8482; vaccine, Emergent&#8217;s anthrax franchise includes the BioThrax&#174; vaccine, which will continue to serve a critical purpose, as well as two treatments, Anthrasil&#174; &#91;Anthrax Immune Globulin Intravenous (human)&#93;, a polyclonal antibody therapeutic, and raxibacumab, a monoclonal antibody therapeutic.</font></div></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro Semibold',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="image.jpg" src="image.jpg" style="height:35px;margin-bottom:5pt;vertical-align:text-bottom;width:306px"></div></div><div style="border-color:#ffffff;border-style:solid;border-width:1.00pt;padding:72.00pt 0.00pt 43.20pt 0.00pt"><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The FDA approval of CYFENDUS&#8482; vaccine is based on data from a series of studies supported by the U.S. government and conducted by Emergent, including&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8211;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.24pt">a pivotal Phase 3 clinical study that evaluated the lot consistency, immunogenicity, and safety of the vaccine following a two-dose schedule administered intramuscularly in healthy adults, </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8211;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.24pt">a Phase 2 study that evaluated non-interference between the vaccine and antibacterial drugs approved for post-exposure prophylaxis of anthrax disease, and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8211;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:12.24pt">non-clinical studies that assessed protective efficacy of the vaccine against lethal challenge with anthrax spores and helped identify neutralizing antibody levels associated with protection against disease.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The Biologics License Application submission and attainment of product licensure were completed under contract number HHSO100201600030C for the advanced development and delivery of CYFENDUS&#8482; vaccine, funded by BARDA, within the Administration for Strategic Preparedness and Response in the U.S. Department of Health and Human Services. Early-stage development funding was also provided by NIAID, part of the National Institutes of Health, and DARPA of the U.S. Department of Defense.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">About CYFENDUS&#8482; (Anthrax Vaccine Adsorbed, Adjuvanted) </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Indication</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">CYFENDUS&#8482; (Anthrax Vaccine Absorbed, Adjuvanted) is a vaccine indicated for post-exposure prophylaxis of anthrax disease following suspected or confirmed exposure to </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Bacillus anthracis</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> in persons 18 through 65 years of age when given with recommended antibacterial drugs. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The efficacy of CYFENDUS&#8482; vaccine for post-exposure prophylaxis (PEP) is based solely on studies in animal models of inhalational anthrax.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Important Safety Information </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Contraindication&#58;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> Do not take CYFENDUS&#8482; vaccine if you are allergic to CYFENDUS&#8482; vaccine, BioThrax&#174; (Anthrax Vaccine Adsorbed) or any ingredient of the vaccine. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Allergic reactions&#58;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> Appropriate medical treatment and supervision must be available after receiving CYFENDUS&#8482; vaccine to manage possible serious allergic reactions. Get medical help right away if you have any symptoms of a serious allergic reaction.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Altered Immunocompetence&#58;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> Immunocompromised persons, including individuals receiving immunosuppressive therapy, may have a diminished immune response to CYFENDUS&#8482; vaccine. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Pregnancy&#58; </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">CYFENDUS&#8482; vaccine can cause fetal harm when administered to a pregnant individual. Before getting CYFENDUS&#8482; vaccine, tell your healthcare provider if you may be pregnant, plan to get pregnant soon, or are nursing a baby.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Adverse reactions&#58;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> The most common adverse reactions reported were tenderness, pain, warmth, itching, swelling, redness, bruising, arm motion limitations, muscle aches, tiredness, headache, and fever.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">U.S. Prescribing Information</font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The full Prescribing Information for CYFENDUS&#8482; vaccine can be found </font><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">here</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">. If it is not currently available via this link, it will be visible as soon as possible as the company works to finalize the document. Please check back for the full information shortly.</font></div></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro Semibold',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><img alt="image.jpg" src="image.jpg" style="height:35px;margin-bottom:5pt;vertical-align:text-bottom;width:306px"></div></div><div style="border-color:#ffffff;border-style:solid;border-width:1.00pt;padding:72.00pt 0.00pt 43.20pt 0.00pt"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">About Emergent BioSolutions</font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">At Emergent, our mission is to protect and enhance life. For over 20 years, we&#8217;ve been at work defending people from things we hope will never happen&#8212;so we are prepared, just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our </font><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">website</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> and follow us on </font><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">LinkedIn</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">, </font><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Twitter</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">, and </font><font style="color:#0000ff;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Instagram</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Safe Harbor Statement</font></div><div><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including statements regarding the development, availability, and government procurement of CYFENDUS</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> vaccine and the continued development of Emergent&#8217;s anthrax franchise, are forward-looking statements. We generally identify forward-looking statements by using words like &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221;</font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8220;plan,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; and similar expressions or variations thereof, or the negative thereof, but these terms are not the exclusive means of identifying such statements. Forward-looking statements are based on our current intentions, beliefs, and expectations regarding future events. We cannot guarantee that any forward-looking statement will be accurate. Readers should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from our expectations. Readers are, therefore, cautioned not to place undue reliance on any forward-looking statement. Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, we do not undertake to update any forward-looking statement to reflect new information, events, or circumstances. Readers should consider this cautionary statement, as well as the risk factors identified in our periodic reports filed with the U.S. Securities and Exchange Commission, when evaluating our forward-looking statements.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro',sans-serif;font-size:11pt;font-weight:400;line-height:112%">###</font></div><div><font><br></font></div><div><font><br></font></div></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Source Sans Pro Semibold',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ebs-20230720.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:99f6285a-8d8a-49b3-a435-d396b398df7f,g:104a0b2d-2799-4bb5-8bbd-49507b0f7ba4-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ebs="http://emergentbiosolutions.com/20230720" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://emergentbiosolutions.com/20230720">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ebs-20230720_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ebs-20230720_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPageCoverPage" roleURI="http://emergentbiosolutions.com/role/CoverPageCoverPage">
        <link:definition>0000001 - Document - Cover Page Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ebs-20230720_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:99f6285a-8d8a-49b3-a435-d396b398df7f,g:104a0b2d-2799-4bb5-8bbd-49507b0f7ba4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_42a4fff8-261d-4924-9d0d-784280d11aea_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a03464e9-611d-40e1-aa9d-85a441973923_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_c2e7b2c0-1fc1-4878-acd6-13b2552ebc18_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_94bc9f71-5144-4429-bd60-265613661643_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_b5746e77-c372-4914-bfba-e0a4040704bf_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_6643fc2c-368d-4073-a7ff-44898376c530_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7d5c8bbe-dc52-4a10-b380-f7e602910146_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_60bfc25c-6062-4926-881d-e032803ac64b_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_27deace5-3b9d-460f-bb34-9e4ce3b5b50f_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_4b8cbf29-ce3b-442e-8edc-2b5382cc4e34_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_f31371ac-7f48-4c9e-b893-73dc46948b45_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_5188143b-1430-4373-be6d-2b27525f7c94_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_d970c689-8a01-4394-a335-6acd9be960df_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_997c1bcc-29a8-414b-b4b4-7fe57f5e2ed7_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d5fbeaef-41c4-444e-87fb-6c120ac1e7c0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_4258a980-7fdd-41a8-954e-da2296e0fe1f_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_d929e112-9bf4-4feb-aaa4-dfa2f332a5bc_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_8fcd148d-3386-46d7-a100-1790989cdeb3_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_811e025e-630a-4039-bf43-46e33818836d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_027c3e6e-6890-49d2-9854-e0b5574efdca_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_41118991-2279-44f1-9366-216b9b29d1be_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_d5ba8863-6403-4033-9f25-b150b6046fb9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_791ea24d-39b0-42e6-a6e2-0a477984d16f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_e48cbe43-2d04-448c-b3b3-bcfbb635b1a1_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ebs-20230720_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:99f6285a-8d8a-49b3-a435-d396b398df7f,g:104a0b2d-2799-4bb5-8bbd-49507b0f7ba4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://emergentbiosolutions.com/role/CoverPageCoverPage" xlink:type="simple" xlink:href="ebs-20230720.xsd#CoverPageCoverPage"/>
  <link:presentationLink xlink:role="http://emergentbiosolutions.com/role/CoverPageCoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_574bf316-a4c0-4d55-bd21-e031b04af234" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_DocumentType_574bf316-a4c0-4d55-bd21-e031b04af234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_41bc5bcd-2daa-4102-9e7e-5795292f3ca6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_DocumentPeriodEndDate_41bc5bcd-2daa-4102-9e7e-5795292f3ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c1015bf5-196c-4194-a50b-10681cc5e19d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_EntityRegistrantName_c1015bf5-196c-4194-a50b-10681cc5e19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_78bb09d7-5bfe-4a03-af20-8b3315245bdd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_EntityIncorporationStateCountryCode_78bb09d7-5bfe-4a03-af20-8b3315245bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_415bbe55-b07a-4ce9-874e-f04002c9d960" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_EntityFileNumber_415bbe55-b07a-4ce9-874e-f04002c9d960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b3b90f1d-a02e-4dc5-9f45-87881418734f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_EntityTaxIdentificationNumber_b3b90f1d-a02e-4dc5-9f45-87881418734f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_a15e0469-0a35-448d-a7da-162a3cff182d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_EntityAddressAddressLine1_a15e0469-0a35-448d-a7da-162a3cff182d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_1433781c-e025-48d3-8869-f0043e4a82d7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_EntityAddressAddressLine2_1433781c-e025-48d3-8869-f0043e4a82d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b48921ac-b6c2-4e0a-b28e-2e605cb6de56" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_EntityAddressCityOrTown_b48921ac-b6c2-4e0a-b28e-2e605cb6de56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_55c7652b-0f90-464a-87cc-38986b31bbfe" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_EntityAddressStateOrProvince_55c7652b-0f90-464a-87cc-38986b31bbfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a7a37117-40a4-4fc7-b497-88b503697ac6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_EntityAddressPostalZipCode_a7a37117-40a4-4fc7-b497-88b503697ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_170bc0bb-03b3-480e-ba40-75a669cc6a27" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_CityAreaCode_170bc0bb-03b3-480e-ba40-75a669cc6a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_82f0a9fd-5a62-455e-9319-4c53b65d66b9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_LocalPhoneNumber_82f0a9fd-5a62-455e-9319-4c53b65d66b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_37b608e6-3546-4d9b-aa6a-14dfd4af62a9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_WrittenCommunications_37b608e6-3546-4d9b-aa6a-14dfd4af62a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_5751c940-f48e-489c-bb50-16032dc173e3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_SolicitingMaterial_5751c940-f48e-489c-bb50-16032dc173e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_edd2fe47-38cf-4989-9933-4aedf74f9c0f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_PreCommencementTenderOffer_edd2fe47-38cf-4989-9933-4aedf74f9c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_0704a90a-baaf-4136-a105-3eef7016dae5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_0704a90a-baaf-4136-a105-3eef7016dae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4670c51a-081b-4b6e-bbb0-446941ae8908" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_EntityEmergingGrowthCompany_4670c51a-081b-4b6e-bbb0-446941ae8908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8bb896f1-d932-402d-ae5b-16b8515b7aae" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_Security12bTitle_8bb896f1-d932-402d-ae5b-16b8515b7aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b55f4f14-247a-4e25-bfa9-3da0e33da236" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_TradingSymbol_b55f4f14-247a-4e25-bfa9-3da0e33da236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_1455cfec-0252-4fe4-ac19-92cdf3264bb6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_SecurityExchangeName_1455cfec-0252-4fe4-ac19-92cdf3264bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_235c6bcb-4ec6-4a4f-80aa-86408175ed1d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_EntityCentralIndexKey_235c6bcb-4ec6-4a4f-80aa-86408175ed1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_3c85423f-78af-4450-9bbd-750edc2e45e0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_60228994-577d-4c82-829d-b9ae08c78fb1" xlink:to="loc_dei_AmendmentFlag_3c85423f-78af-4450-9bbd-750edc2e45e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image.jpg
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MUZY=0U:M7*G?@TMGS\B6;X;+U#H/J;>_7\R2JYCOS AMS<"N<N'D[QHGD&H
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M/Z.R++YFAHS,9M:O*+NFC\_P-0/41<4*Y?3&#KSEB906-ZR0_=V>_93#+V2
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MS9 Y36K(Q,?S91$S'&?Q-6-#^MF#>V,>E5G<L$+&OKA$PU4 $(N0V;@L'+.
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3-((HALK-I     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140233836184480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page Cover Page<br></strong></div></th>
<th class="th"><div>Jul. 20, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 20,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EMERGENT BIOSOLUTIONS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">14-1902018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">400 Professional Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Gaithersburg<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">631-3200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EBS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001367644<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>ebs-20230720_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ebs-20230720.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367644</identifier>
        </entity>
        <period>
            <startDate>2023-07-20</startDate>
            <endDate>2023-07-20</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-23">0001367644</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-24">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2023-07-20</dei:DocumentPeriodEndDate>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-07-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-4">EMERGENT BIOSOLUTIONS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-5">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-33137</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-7">14-1902018</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-8">400 Professional Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-9">Suite 400</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Gaithersburg</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">20879</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">240</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">631-3200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-16">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-19">Common Stock, Par Value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-20">EBS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-21">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MTG1X#SY['R73>RHY_U=3_ 102P,$%     @ -$/U5I>*NQS     $P(   L
M  !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%
MG;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XU
MA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.
M\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,B
MM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    "  T0_56Y6B*[#D!
M   R @  #P   'AL+W=O<FMB;V]K+GAM;(U1T6[", S\E2H?L)9I0QJBO("V
M(4T;&A/OH76I11)7C@L;7S^W50727O9D^VQ=[B[S,_%Q3W1,OKT+,3>U2#-+
MTUC4X&V\HP:";BIB;T5'/J2Q8;!EK '$N_0^RZ:IMQC,8CYR;3B]'4B@$*2@
M8 ?L$,[QNN_&Y(01]^A0?G+3]PY,XC&@QPN4N<E,$FLZOQ+CA8)8MRV8G,O-
M9%CL@ 6+/_"V$_EE][%'Q.X_K0K)S313P@HY2G_1\UO5> (]'J96Z!F= *^L
MP M3VV X=#3J(KVQT><PUB'$&?\G1JHJ+&!%1>LAR) C@^L$AEAC$TT2K(?<
M+.D$G&SL 9)KV_G3!]?EX%54Y$UR/$-=\+H<Y(X:2Z@P0/FNM%%QS:O8<-*5
MGN?^X7'RI+FTSBT5^PAO9,O1\OA=BU]02P,$%     @ -$/U5B0>FZ*M
M^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E
M #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&
M:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T
M==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)
M(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( #1#]59ED'F2
M&0$  ,\#   3    6T-O;G1E;G1?5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N
M+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78
ME!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')O
MJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<
M^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!G
MZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.
M6X.^D<WC_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L!
M A0#%     @ -$/U5@=!36*!    L0   !               ( !     &1O
M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  T0_56F7;V\N\    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  T
M0_56F5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( #1#]5:=(L>*:00  #<1   8
M  " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  T
M0_56GZ ;\+$"  #B#   #0              @ &M#   >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( #1#]5:7BKL<P    !,"   +              "  8D/
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( #1#]5;E:(KL.0$  #("   /
M          "  7(0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  T0_56
M)!Z;HJT   #X 0  &@              @ '8$0  >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    "  T0_5699!YDAD!  #/ P  $P
M        @ &]$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"
(   '%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ebs-20230720.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://emergentbiosolutions.com/role/CoverPageCoverPage</Role>
      <ShortName>Cover Page Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ebs-20230720.htm">ebs-20230720.htm</File>
    <File>a072023-av7909cyfendusappr.htm</File>
    <File>ebs-20230720.xsd</File>
    <File>ebs-20230720_lab.xml</File>
    <File>ebs-20230720_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ebs-20230720.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ebs-20230720.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ebs-20230720_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ebs-20230720_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ebs-20230720.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ebs",
   "nsuri": "http://emergentbiosolutions.com/20230720",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230720.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://emergentbiosolutions.com/role/CoverPageCoverPage",
     "shortName": "Cover Page Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ebs-20230720.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://emergentbiosolutions.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001367644-23-000135-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001367644-23-000135-xbrl.zip
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MQGZ!0 ''(29Z?'QT=MHL1D_^W!K12>F\]K57I&A'>0YFS?FNDS)5A = M^.
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M/X5@/#<3'3OQDXY#R0Z).E@;VI.4)CG'^R/[\1Z;;/N@;<*3\X-D,#/8'^?
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M%'KWMA=ZGX;O1WW*W\OZ'U!+ P04    "  T0_56FSB'C5(0  #R<P  $
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MS'$TS=_UXQ HP'KH5'!T+24Y>&%+J5NL<_ NN+\!^R1CNS3=Y".+F !KW8F
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M,]XXS]B@7+66:ZW>4JRW4NO:B#=;:]N']S9LF#;<U:L./?A.)WJTX,UQ!^[
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M(6U9JT4>&VQ/XKQ2G3UM=;OVX];9A"/S9IF_$W"-N78BKAYI,.0:$]ADKGE
MU^WMF0F4\]FG5.F'?^O':11+A6BD "%1 &B@0L 1A "%#+*(2:6%]8\[-<XP
M-@A7.[652J^2Z1F=KKO9ET;:;F1[V#/,'M;>F0Z;UY;L>^Q;7T8<>,O:DM#V
M;K5M8%>0/R:S]4_>10AIB'T- @(YH) P8%928FC6AFH41210;@P_!Q\IOJ5
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M)BV3#71<K_)Y[&&BF'"G<D>T3DL<ITUS!?67OE!-I;-=C>P<^L)$1ARCB@B
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MC'M&Z@'<L.A/N OY<O)V%O4WBT?DG>&!H[W['[J7[N\51WM_ E!+ 0(4 Q0
M   ( #1#]599J!=<[Q$  )Y5   >              "  0    !A,#<R,#(S
M+6%V-SDP.6-Y9F5N9'5S87!P<BYH=&U02P$"% ,4    "  T0_56FSB'C5(0
M  #R<P  $               @ $K$@  96)S+3(P,C,P-S(P+FAT;5!+ 0(4
M Q0    ( #1#]5;)_"O8?0(  *\'   0              "  :LB  !E8G,M
M,C R,S W,C N>'-D4$L! A0#%     @ -$/U5D0_2]BT"@  1&(  !0
M         ( !5B4  &5B<RTR,#(S,#<R,%]L86(N>&UL4$L! A0#%     @
M-$/U5C<@$97I!@  +C,  !0              ( !/#   &5B<RTR,#(S,#<R
?,%]P<F4N>&UL4$L%!@     %  4 3 $  %<W      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
